chevron_leftBack
As of 18 June 2026, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has a market cap of $1.82B USD, ranking #7530 globally and #1886 in China.
It ranks #610 in the Healthcare sector, and #240 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$1.82BUSD
12.31B CNY
Enterprise Value
$1.62BUSD
10.92B CNY
Revenue (TTM)
$772.25MUSD
5.22B CNY
EBITDA (TTM)
$230.12MUSD
1.56B CNY
Net Income (TTM)
$96.47MUSD
651.95M CNY
EBITDA Margin
30%
Profit Margin
12%
PE Ratio
19.1
Forward PE
12.2
PS Ratio
2.4
PB Ratio
1.4
EV/EBITDA
7.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yi Jiang Mei
open_in_new
Employees
5,001
Founded
1973
Website
jiuzhoupharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.2% | -17% | -17% | -25% | -31% | -0.9% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
603456
浙江九洲药业股份有限公司 Class A
ISIN: CNE100001W36
Shares Out.:
Shares Outstanding:
881.71M1
Shares Float:
503.196M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.79 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.99B
3K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.77B
3K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
1K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
932%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
809%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
779%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
42K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
30K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
20K%
|
97.4
|
|
SIX: RO
|
$323.08B
18K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.5B
16K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.99B
15K%
218.9B CHF
|
20.5
|
chevron_leftBack